Skip to main content
. Author manuscript; available in PMC: 2020 Sep 3.
Published in final edited form as: Mol Pharm. 2019 Aug 16;16(9):3831–3841. doi: 10.1021/acs.molpharmaceut.9b00464

Figure 1.

Figure 1.

(A) The design of boron labeled PSMA targeted agents includes a urea based inhibitory element, connected to a boron containing substituent via a linker moiety. (B) Structures of boron labeled PSMA agents evaluated in this study.